Irma Ramos-Oliver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Irma Ramos-Oliver has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Alba Antón-Jiménez
Department of General Radiology, Vall d'Hebron University Hospital, Barcelona, Spain
1 shared publication Alejandro Alegría
1 shared publication- Alex Lluch-Bergueda
From the Musculoskeletal Radiology Section, Department of Radiology (A.A.J., M.T.V.A., A.G.C., M.d.A.D., C.T.O., L.C.G., N.O.S., R.D.O.), Musculoskeletal Pathology Section, Department of Pathology (I.R.O.), and Hand Surgery Section, Department of Traumatology and Orthopedics Surgery (Á.L.B.), Vall d’Hebron University Hospital, Passeig de la Vall d’Hebron, 119, 08035 Barcelona, Spain
1 shared publication - Alfredo Gimeno Cajal
From the Musculoskeletal Radiology Section, Department of Radiology (A.A.J., M.T.V.A., A.G.C., M.d.A.D., C.T.O., L.C.G., N.O.S., R.D.O.), Musculoskeletal Pathology Section, Department of Pathology (I.R.O.), and Hand Surgery Section, Department of Traumatology and Orthopedics Surgery (Á.L.B.), Vall d’Hebron University Hospital, Passeig de la Vall d’Hebron, 119, 08035 Barcelona, Spain
1 shared publication - Anna Petit
Pathology Department, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain
1 shared publication Anna Pigem Rodeja
General and Digestive Surgery Research Group Girona Biomedical Research Institute (IDIBGI) Girona Spain
1 shared publication
Latest Publications
- Open Access
- 26 September 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 288
Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma
- 26 September 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 288
Open AccessInflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma
- 7 December 2025
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (1) , e70157
Adipose tissue metabolomics identifies disease stage and tumour invasiveness of rectal cancer
Backgorund: Adipose tissue has emerged as a prognostic factor in rectal cancer (RC), yet its metabolic role in tumour progression remains poorly understood. This study aims to characterise the metabolic profiles of subcutaneous (SAT) and visceral adipose tissue (VAT) in early and advanced tumours to investigate metabolic alterations that may influence tumour progression. Understanding these alterations could provide insights into mechanisms of rectal cancer and identify therapeutic targets. Methods: Global metabolic profiles of 68 SAT and VAT samples from patients with RC were analyzed using high‐performance chemical isotope labeling liquid chromatography mass spectrometry. Statistical analyses were stratified by clinical tumour invasion and disease stage. Results: VAT exhibited distinct metabolic signatures between early and advanced tumour invasion. Advanced tumours (cT3‐4) had a higher concentration of N‐glycolylneuraminic acid and phenylacetylglutamine, whereas early invasive tumours (cT2) exhibited higher levels of dipeptides. Pathway enrichment analyses revealed dysregulations in taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism, propanoate metabolism and cellular signalling pathways in advanced invasion. Propanoate metabolism emerged as a key pathway distinguishing early and advanced invasion stages. In SAT, metabolic changes aligned with overall disease stage. Early‐stage disease was associated with a higher concentration of dipeptides, whereas advanced stages showed increased N‐acetyl‐agmatine and N‐acetyl‐L‐noradrenaline. Conclusions: Our study highlights significant metabolic alterations in adipose tissue associated with rectal cancer progression. VAT metabolism reflects tumour invasiveness, while SAT is more indicative of disease stage. Propanoate metabolism may serve as a biomarker for advanced invasion, offering potential for improved staging, reclassification and personalised therapeutic strategies.
- 7 December 2025
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (1) , e70157
Adipose tissue metabolomics identifies disease stage and tumour invasiveness of rectal cancer
Backgorund: Adipose tissue has emerged as a prognostic factor in rectal cancer (RC), yet its metabolic role in tumour progression remains poorly understood. This study aims to characterise the metabolic profiles of subcutaneous (SAT) and visceral adipose tissue (VAT) in early and advanced tumours to investigate metabolic alterations that may influence tumour progression. Understanding these alterations could provide insights into mechanisms of rectal cancer and identify therapeutic targets. Methods: Global metabolic profiles of 68 SAT and VAT samples from patients with RC were analyzed using high‐performance chemical isotope labeling liquid chromatography mass spectrometry. Statistical analyses were stratified by clinical tumour invasion and disease stage. Results: VAT exhibited distinct metabolic signatures between early and advanced tumour invasion. Advanced tumours (cT3‐4) had a higher concentration of N‐glycolylneuraminic acid and phenylacetylglutamine, whereas early invasive tumours (cT2) exhibited higher levels of dipeptides. Pathway enrichment analyses revealed dysregulations in taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism, propanoate metabolism and cellular signalling pathways in advanced invasion. Propanoate metabolism emerged as a key pathway distinguishing early and advanced invasion stages. In SAT, metabolic changes aligned with overall disease stage. Early‐stage disease was associated with a higher concentration of dipeptides, whereas advanced stages showed increased N‐acetyl‐agmatine and N‐acetyl‐L‐noradrenaline. Conclusions: Our study highlights significant metabolic alterations in adipose tissue associated with rectal cancer progression. VAT metabolism reflects tumour invasiveness, while SAT is more indicative of disease stage. Propanoate metabolism may serve as a biomarker for advanced invasion, offering potential for improved staging, reclassification and personalised therapeutic strategies.
- 21 September 2025
- Published by Springer Nature
- Vol. 40 (1) , 165-175
Segmenting Invasive and In Situ Carcinoma in Breast WSIs with a Pretrained Histopathology Transformer
- 21 September 2025
- Published by Springer Nature
- Vol. 40 (1) , 165-175
Segmenting Invasive and In Situ Carcinoma in Breast WSIs with a Pretrained Histopathology Transformer
- 1 May 2022
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 42 (3) , E96-E97
Spectrum of Soft-Tissue Lesions of the Finger
Soft-tissue lesions of the finger are common and often benign, and a multimodality imaging approach is mandatory for therapeutic planning.
- 1 May 2022
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 42 (3) , E96-E97
Spectrum of Soft-Tissue Lesions of the Finger
Soft-tissue lesions of the finger are common and often benign, and a multimodality imaging approach is mandatory for therapeutic planning.
- Top Cited Papers
- 1 March 2020
- Published by Elsevier in Laboratory Investigation
- Vol. 33 (3) , 404-419
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation
- 1 March 2020
- Published by Elsevier in Laboratory Investigation
- Vol. 33 (3) , 404-419
Top Cited PapersA subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation